| Infliximab earning place as Crohn's first-line Rx.(Report): An article from: Internal Medicine News | Digitalby Damian McNamara (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 3 Pages | | Publication Date: | November 15, 2008 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on November 15, 2008. The length of the article is 672 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Infliximab earning place as Crohn's first-line Rx.(Report)Author: Damian McNamaraPublication: Internal Medicine News (Magazine/Journal)Date: November 15, 2008Publisher: International Medical News GroupVolume: 41 Issue: 22 Page: 29(1)Article Type: ReportDistributed by Gale, a part of Cengage Learning |
|
